|
|
||||||||
Articles |
Neuroimaging Section, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, MD 20892.
Cerebral necrosis after radiotherapy for brain tumors is being recognized as a problem more common than previously estimated. Distinction between this iatrogenic complication and tumor recurrence cannot be made by either CT or MR imaging. By using positron emission tomography (PET) with 18F-deoxyglucose (FDG) we were able to reach a diagnosis of radiation necrosis, later verified, in 10 of 95 patients referred for the purpose of differentiating tumor recurrence from necrosis. The critical PET-FDG feature was focal hypometabolism in the area of necrosis, which contrasted with the hypermetabolism associated with the residual/recurrent tumor. In addition, four cases of cerebral necrosis after supraophthalmic, intraarterial chemotherapy (BCNU) were studied with the PET-FDG method. The area of chemotherapy damage was also characterized by marked hypometabolism. Histology revealed both similarities and differences between radio- and chemonecrosis.
This article has been cited by other articles:
![]() |
Y. Terakawa, N. Tsuyuguchi, Y. Iwai, K. Yamanaka, S. Higashiyama, T. Takami, and K. Ohata Diagnostic Accuracy of 11C-Methionine PET for Differentiation of Recurrent Brain Tumors from Radiation Necrosis After Radiotherapy J. Nucl. Med., May 1, 2008; 49(5): 694 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Brandes, A. Tosoni, F. Spagnolli, G. Frezza, M. Leonardi, F. Calbucci, and E. Franceschi Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology Neuro-oncol, January 1, 2008; 10(3): 361 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen Clinical Applications of PET in Brain Tumors J. Nucl. Med., September 1, 2007; 48(9): 1468 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Kim, S.-w. Lee, S. Y. Nam, K. C. Im, J.-S. Kim, S. J. Oh, S. D. Ahn, S. S. Shin, E. K. Choi, and J. H. Kim The Feasibility of 18F-FDG PET Scans 1 Month After Completing Radiotherapy of Squamous Cell Carcinoma of the Head and Neck J. Nucl. Med., March 1, 2007; 48(3): 373 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ceyssens, K. Van Laere, T. de Groot, J. Goffin, G. Bormans, and L. Mortelmans [11C]Methionine PET, Histopathology, and Survival in Primary Brain Tumors and Recurrence AJNR Am. J. Neuroradiol., August 1, 2006; 27(7): 1432 - 1437. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, D. H.S. Silverman, S. Delaloye, J. Czernin, N. Kamdar, W. Pope, N. Satyamurthy, C. Schiepers, and T. Cloughesy 18F-FDOPA PET Imaging of Brain Tumors: Comparison Study with 18F-FDG PET and Evaluation of Diagnostic Accuracy J. Nucl. Med., June 1, 2006; 47(6): 904 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Fukui, T. M. Blodgett, C. H. Snyderman, J. J. Johnson, E. N. Myers, D. W. Townsend, and C. C. Meltzer Combined PET-CT in the Head and Neck: Part 2. Diagnostic Uses and Pitfalls of Oncologic Imaging RadioGraphics, July 1, 2005; 25(4): 913 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, T. Cloughesy, N. Kamdar, N. Satyamurthy, M. Bergsneider, L. Liau, P. Mischel, J. Czernin, M. E. Phelps, and D. H.S. Silverman Imaging Proliferation in Brain Tumors with 18F-FLT PET: Comparison with 18F-FDG J. Nucl. Med., June 1, 2005; 46(6): 945 - 952. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Borgwardt, L. Hojgaard, H. Carstensen, H. Laursen, M. Nowak, C. Thomsen, and K. Schmiegelow Increased Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose (FDG) Uptake in Childhood CNS Tumors Is Correlated With Malignancy Grade: A Study With FDG Positron Emission Tomography/Magnetic Resonance Imaging Coregistration and Image Fusion J. Clin. Oncol., May 1, 2005; 23(13): 3030 - 3037. [Abstract] [Full Text] [PDF] |
||||
![]() |
J B Bingham Where can FDG-PET contribute most to anatomical imaging problems? Br. J. Radiol., November 1, 2002; 75(90009): S39 - 52. [Full Text] [PDF] |
||||
![]() |
H.-P. Schlemmer, P. Bachert, K. K. Herfarth, I. Zuna, J. Debus, and G. van Kaick Proton MR Spectroscopic Evaluation of Suspicious Brain Lesions After Stereotactic Radiotherapy AJNR Am. J. Neuroradiol., August 1, 2001; 22(7): 1316 - 1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Langleben and G. M. Segall PET in Differentiation of Recurrent Brain Tumor from Radiation Injury J. Nucl. Med., November 1, 2000; 41(11): 1861 - 1867. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Kumar, N. E. Leeds, G. N. Fuller, P. Van Tassel, M. H. Maor, R. E. Sawaya, and V. A. Levin Malignant Gliomas: MR Imaging Spectrum of Radiation Therapy- and Chemotherapy-induced Necrosis of the Brain after Treatment Radiology, November 1, 2000; 217(2): 377 - 384. [Abstract] [Full Text] |
||||
![]() |
J. M. Wilmshurst, S. F. Barrington, D. Pritchard, T. Cox, P. Bullock, M. Maisey, and R. O. Robinson Positron Emission Tomography in Imaging Spinal Cord Tumors J Child Neurol, July 1, 2000; 15(7): 465 - 472. [Abstract] [PDF] |
||||
![]() |
H. J. Aronen, F. S. Pardo, D. N. Kennedy, J. W. Belliveau, S. D. Packard, D. W. Hsu, F. H. Hochberg, A. J. Fischman, and B. R. Rosen High Microvascular Blood Volume Is Associated with High Glucose Uptake and Tumor Angiogenesis in Human Gliomas Clin. Cancer Res., June 1, 2000; 6(6): 2189 - 2200. [Abstract] [Full Text] |
||||
![]() |
T. Sugahara, Y. Korogi, S. Tomiguchi, Y. Shigematsu, I. Ikushima, T. Kira, L. Liang, Y. Ushio, and M. Takahashi Posttherapeutic Intraaxial Brain Tumor: The Value of Perfusion-sensitive Contrast-enhanced MR Imaging for Differentiating Tumor Recurrence from Nonneoplastic Contrast-enhancing Tissue AJNR Am. J. Neuroradiol., May 1, 2000; 21(5): 901 - 909. [Abstract] [Full Text] |
||||
![]() |
L. Aloj, C. Caraco, E. Jagoda, W. C. Eckelman, and R. D. Neumann Glut-1 and Hexokinase Expression: Relationship with 2-Fluoro-2-deoxy-D-glucose Uptake in A431 and T47D Cells in Culture Cancer Res., September 1, 1999; 59(18): 4709 - 4714. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. U Berlangieri, A. M Scott, S. R Knight, G. J Fitt, O. F Hennessy, H. J Tochon-Danguy, C Peter Clarke, and W John McKay F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer Eur. J. Cardiothorac. Surg., September 1, 1999; 16(suppl_1): S25 - S30. [Abstract] [Full Text] [PDF] |
||||
![]() |
R O Robinson, C D Ferrie, M Capra, and M N Maisey Positron emission tomography and the central nervous system Arch. Dis. Child., September 1, 1999; 81(3): 263 - 270. [Full Text] |
||||
![]() |
D. Delbeke, W. H. Martin, M. P. Sandler, W. C. Chapman, J. K. Wright Jr, and C. W. Pinson Evaluation of Benign vs Malignant Hepatic Lesions With Positron Emission Tomography Arch Surg, May 1, 1998; 133(5): 510 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cha, E. A. Knopp, G. Johnson, S. G. Wetzel, A. W. Litt, and D. Zagzag Intracranial Mass Lesions: Dynamic Contrast-enhanced Susceptibility-weighted Echo-planar Perfusion MR Imaging Radiology, April 1, 2002; 223(1): 11 - 29. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |